Literature DB >> 27487105

Moving beyond monotherapy in the immunotherapeutic arena: prospects for combination therapies in lung cancer.

Scott J Antonia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27487105

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  2 in total

1.  Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients.

Authors:  Cristina Maccalli; Diana Giannarelli; Carla Chiarucci; Ornella Cutaia; Gianluca Giacobini; Wouter Hendrickx; Giovanni Amato; Diego Annesi; Davide Bedognetti; Maresa Altomonte; Riccardo Danielli; Luana Calabrò; Anna Maria Di Giacomo; Francesco M Marincola; Giorgio Parmiani; Michele Maio
Journal:  Oncoimmunology       Date:  2017-05-08       Impact factor: 8.110

2.  Safety and Efficacy of Tianfoshen Oral Liquid in Non-Small Cell Lung Cancer Patients as an Adjuvant Therapy.

Authors:  Lei Zhao; Jing Wang; Huihui Li; Juanjuan Che; Nina Ma; Bangwei Cao
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-03       Impact factor: 2.629
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.